NOTIFICATION OF MAJOR HOLDINGS |
|
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
BioPharma Credit PLC |
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) |
Non-UK issuer |
|
2. Reason for the notification (please mark the appropriate box or boxes with an "X") |
An acquisition or disposal of voting rights |
|
An acquisition or disposal of financial instruments |
|
An event changing the breakdown of voting rights |
|
Other (please specify): Adage % of Voting Rights decreased due to Equity Offering listed on 05/11/2018 increasing Total Voting Rights (prior to the offering, there was also the conversion of GB00BDRNW621 to GB00BDGKMY29) |
x |
3. Details of person subject to the notification obligation |
Name |
Adage Capital Partners GP LLC |
City and country of registered office (if applicable) |
Boston, MA, USA |
4. Full name of shareholder(s) (if different from 3.) |
Name |
Morgan Stanley & Co LLC GB00BDGKMY29 common stock 25,284,247 JP Morgan Securities LLC GB00BDGKMY29 common stock 73,829,440 |
City and country of registered office (if applicable) |
New York, NY USA |
5. Date on which the threshold was crossed or reachedvi: |
05/11/2018 |
6. Date on which issuer notified (DD/MM/YYYY): |
12/11/2018 |
7. Total positions of person(s) subject to the notification obligation |
|
% of voting rights attached to shares (total of 8. A) |
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights of issuer |
Resulting situation on the date on which threshold was crossed or reached |
7.21% |
N/A |
7.21% |
1,373,932,067 |
Position of previous notification (if applicable) |
9.25% |
N/A |
9.25% |
|
|
|
|
|
|
|
|